Upstream open reading frame translation enhances immunogenic peptide presentation in mitotically arrested cancer cells
Alexander KowariD, Jonas Philipp BeckeriD, Rossella Del Pizzo, Zhiwei TangiD, Julien ChampagneiD, Kathrin WellachiD, Kiana Samimi, Ariel Galindo‐AlbarrániD, Pierre-René KörneriD, Jasmine Montenegro NavarroiD, Andres M. EliaiD, Fiona Megan Tilghman, Hanan SakeeriD, Marco Antonio Mendoza-ParraiD, Angelika Beate RiemeriD, Reuven AgamiiD, Fabricio Loayza‐PuchiD
Abstract
Mitosis is a critical phase of the cell cycle and a vulnerable point where cancer cells can be effectively disrupted, leading to cell death and inhibition of tumor growth. However, challenges such as drug resistance remain significant in clinical applications. During mitosis, mRNA translation is generally downregulated, while non-canonical translation of specific transcripts proceeds. Here, we demonstrate that mitotic cancer cells redistribute ribosomes toward the 5 untranslated region (5 UTR) and the start of the coding sequence (CDS), enhancing the translation of thousands of upstream open reading frames (uORFs) and upstream overlapping open reading frames (uoORFs). This mitotic induction of uORF/uoORF enriches the presentation of immunopeptides at the surface of cancer cells following treatment with mitotic inhibitors. Functional assays indicate the potential of such neoepitopes to provoke cancer-cell killing by T cells. Altogether, our findings highlight the therapeutic potential of targeting uORF/uoORF-derived neoepitopes in combination with mitotic inhibitors to enhance immune recognition and tumor cell elimination.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 10
- FWCI
- 2.99
- Field percentile
- top 8%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Targeting a shared neoepitope derived from non-canonical translation of c-MYC oncogene in cancer cells
Estelle Baulu, A. Bolon, … Stéphane Depil·bioRxiv·May 23, 2024
- Thousands of novel unannotated proteins expand the MHC I immunopeptidome in cancer
T. Ouspenskaia, T. Law, … A. Regev·bioRxiv·Feb 12, 2020
- Depletion of rRNA Methyltranferase METTL5 Enhances Anti-Tumor Immune Response via Neoantigen Generated from Cryptic Translation
Yangyi Zhang, Xiaoyan Shi, … Hao Chen·bioRxiv·Jun 6, 2025
- Stress-Mediated Attenuation of Translation Undermines T Cell Tumor Control
B. P. Riesenberg, E. G. Hunt, … J. E. Thaxton·bioRxiv·Jan 31, 2022
- eEF2 kinase enhances the expression of PD-L1 by promoting the translation of its mRNA
C. G. Proud, Y. Wu, … J. Li·bioRxiv·Sep 1, 2020
- Induction of an alternative 5’ leader enhances translation of Inpp5e and resistance to oncolytic virus infection
Huy‐Dung Hoang, Tyson Ernst Graber, … Tommy Alain·Cell ReportsPeer-reviewed·Dec 1, 2019